Minal Vasanawala

Professional Education

Fellowship: VA Medical Center Palo Alto (2007) CA

Residency: Stanford University Medical Center - Dept of Radiology (2005) CA

Medical Education: P Dr D Y Patil Medical College (1997) India

Board Certification: Nuclear Medicine, American Board of Nuclear Medicine (2005)

Internship: Stanford Hospital and Clinics - Dept of Surgery (2002) CA

Honors & Awards

Chief Nuclear Medicine Resident, Stanford University Hospital and Clinics (2004)

An Observational Study of Circulating Tumor Cells and F-18-FDG PET Uptake in Patients with Treatment-Naive Non-Small Cell Lung Cancer
Nair, V. S., Keu, K. V., Luttgen, M. S., Kolatkar, A., Vasanawala, M., & Kuhn, P. (2013). An Observational Study of Circulating Tumor Cells and F-18-FDG PET Uptake in Patients with Treatment-Naive Non-Small Cell Lung Cancer. PLOS ONE, 8(7).

An observational study of circulating tumor cells and (18)F-FDG PET uptake in patients with treatment-naive non-small cell lung cancer.
Nair, V. S., Keu, K. V., Luttgen, M. S., Kolatkar, A., Vasanawala, M., & Kuhn, P. (2013). An observational study of circulating tumor cells and (18)F-FDG PET uptake in patients with treatment-naive non-small cell lung cancer. PloS one, 8(7).

A case of three synchronous primary tumors demonstrated by F-18FDG PET
Mittra, E., Vasanawala, M., Niederkohr, R., Rodriguez, C., & Segall, G. (2007). A case of three synchronous primary tumors demonstrated by F-18FDG PET. CLINICAL NUCLEAR MEDICINE, 32(8), 666-667.

F-18 fluorodeoxyglucose PET/CT as an imaging tool for staging and restaging cutaneous angiosarcoma of the scalp
Vasanawala, M. S., Wang, Y., Quon, A., & Gambhir, S. S. (2006). F-18 fluorodeoxyglucose PET/CT as an imaging tool for staging and restaging cutaneous angiosarcoma of the scalp. CLINICAL NUCLEAR MEDICINE, 31(9), 534-537.

Positively labeled white blood cell scan with eosinophilia and absence of infection
Vasanawala, M. S., & Goris, M. L. (2003). Positively labeled white blood cell scan with eosinophilia and absence of infection. CLINICAL NUCLEAR MEDICINE, 28(5), 389-391.